KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Curent Deferred Tax Liability Current Assets Current Deferred Tax Assets Current Taxes Dividends payables Goodwill Goodwill & Intangibles Intangibles Inventory Land & Improvements Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Notes Payables Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Pension Prepaid Assets Property, Plant & Equipment (Net)Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Daily Values

Growth Metrics

Others

Eli Lilly (LLY) Operating Leases (2019)

Historic Operating Leases for Eli Lilly (LLY) over the last 1 years, with Q4 2019 value amounting to $608.4 million.

Eli Lilly's Operating Leases changed N/A to $608.4 million in Q4 2019 from the same period last year, while for Dec 2019 it was $608.4 million, marking a year-over-year change of. This contributed to the annual value of $608.4 million for FY2019, which is N/A changed from last year.
According to the latest figures from Q4 2019, Eli Lilly's Operating Leases is $608.4 million.
Over the past 5 years, Eli Lilly's Operating Leases peaked at $621.9 million during Q1 2019, and registered a low of $608.4 million during Q4 2019.